These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22050351)

  • 1. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
    Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
    Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical guideline for male lower urinary tract symptoms.
    Homma Y; Araki I; Igawa Y; Ozono S; Gotoh M; Yamanishi T; Yokoyama O; Yoshida M;
    Int J Urol; 2009 Oct; 16(10):775-90. PubMed ID: 19811547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.
    Homma Y; Gotoh M; Kawauchi A; Kojima Y; Masumori N; Nagai A; Saitoh T; Sakai H; Takahashi S; Ukimura O; Yamanishi T; Yokoyama O; Yoshida M; Maeda K
    Int J Urol; 2017 Oct; 24(10):716-729. PubMed ID: 28748576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
    Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
    Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian guidelines for the management of benign prostatic hyperplasia.
    Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
    Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?
    Kaplan SA; Olsson CA; Te AE
    J Urol; 1996 Jun; 155(6):1971-4. PubMed ID: 8618299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urological disorders in men: urinary incontinence and benign prostatic hyperplasia.
    Miller SW; Miller MS
    J Pharm Pract; 2011 Aug; 24(4):374-85. PubMed ID: 21984774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive treatment of benign prostatic hyperplasia. Where do we stand in 2005.
    Al-Ansari AA; Shokeir AA
    Saudi Med J; 2006 Mar; 27(3):299-304. PubMed ID: 16532087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Cricelli C; Brenes F; Pedromingo-Marino A; Castro R
    Int J Clin Pract; 2009 Aug; 63(8):1192-7. PubMed ID: 19558487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of symptomatic BPH in Italy: who is treated and how?
    Tubaro A; Montanari E
    Eur Urol; 1999; 36 Suppl 3():28-32. PubMed ID: 10559628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.